|
|
Volumn 315, Issue 8163, 1980, Pages 273-276
|
|
ORAL-CONTRACEPTIVE-ASSOCIATED LIVER TUMOURS: OCCURRENCE OF MALIGNANCY AND DIFFICULTIES IN DIAGNOSIS
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA FETOPROTEIN;
ESTROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS LYNESTRENOL;
ETHINYLESTRADIOL PLUS MEGESTROL ACETATE;
ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;
ETYNODIOL;
ETYNODIOL DIACETATE PLUS MESTRANOL;
LYNESTRENOL;
MEGESTROL;
MESTRANOL;
MESTRANOL PLUS NORETHISTERONE;
NORETHISTERONE;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
ADVERSE DRUG REACTION;
CARCINOGENESIS;
HEPATOMEGALY;
LIVER;
LIVER ADENOMA;
LIVER CANCER;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
ALPHA FETOPROTEINS--ANALYSIS;
BIOLOGY;
BLOOD PROTEINS;
CANCER;
CLINICAL RESEARCH;
CONTRACEPTION;
CONTRACEPTIVE METHODS;
DISEASES;
EXAMINATIONS AND DIAGNOSES;
FAMILY PLANNING;
HEMIC SYSTEM;
HEPATIC EFFECTS;
NEOPLASMS;
ORAL CONTRACEPTIVES;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
ADENOMA;
ADULT;
BLOOD VESSELS;
CARCINOMA, HEPATOCELLULAR;
CONTRACEPTIVES, ORAL;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
NEOPLASM METASTASIS;
|
|
EID: 0018912839
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(80)90776-X Document Type: Article |
|
Times cited : (116)
|
|
References (10)
|
